Casi Pharmaceuticals
(NASDAQ) CASI
Casi Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$26.85M
Net Income (TTM)
$49.38M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CASI News
7 Surprising 5-Star Stocks
5 More Top Small Caps
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Casi Pharmaceuticals
CASI Financials
Key Financial Metrics (TTM)
Gross Margin
36%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
4%
Return on Capital
3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$11.15M
Operating Income
$39.62M
EBITDA
$34.87M
Operating Cash Flow
$29.22M
Capital Expenditure
$240.00K
Free Cash Flow
$29.46M
Cash & ST Invst.
$16.09M
Total Debt
$22.14M
Casi Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$3.08M
-60.5%
Gross Profit
$706.00K
-82.5%
Gross Margin
22.96%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
233
N/A
Net Income
$10.88M
-29.6%
EBITDA
$10.11M
-41.3%
Quarterly Fundamentals
Net Cash
$14.17M
-938.0%
Accounts Receivable
$2.61M
-76.6%
Inventory
$2.61M
-79.8%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$18.86M
N/A
Return on Assets
-2.02%
N/A
Return on Invested Capital
3.01%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A